Mixed-effects models for slope-based endpoints in clinical trials of chronic kidney disease

DOI10.1002/SIM.8282zbMATH Open1546.62775MaRDI QIDQ6628683

Natalie Staplin, Hocine Tighiouart, Jian Ying, [[Person:6189834|Author name not available (Why is that?)]], Edward F. Vonesh, [[Person:6079350|Author name not available (Why is that?)]], Hiddo L. Heerspink, Julia Lewis

Publication date: 29 October 2024

Published in: Statistics in Medicine (Search for Journal in Brave)

zbMATH Keywords

informative censoringshared parameter modelsacute and chronic slopeslinear spline mixed-effects modelspower-of-mean

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites Work

• Title not available (Why is that?)
• Fixed-effect variable selection in linear mixed models using \(R^2\) statistics
• Joint Models for Longitudinal and Time-to-Event Data
• Sample-Size Formula for the Proportional-Hazards Regression Model
• A note on the use of Laplace's approximation for nonlinear mixed-effects models
• The Analysis of Rates and of Survivorship Using Log-Linear Models
• Goodness-of-Fit in Generalized Nonlinear Mixed-Effects Models
• An Approximate Generalized Linear Model with Random Effects for Informative Missing Data
• Modeling the Drop-Out Mechanism in Repeated-Measures Studies

This page was built for publication: Mixed-effects models for slope-based endpoints in clinical trials of chronic kidney disease

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6628683)